TAK-475 Completed Phase 3 Trials for Dyslipidemia Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00487994 | Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia | |
| NCT00143663 | Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol |